Index by author
April 01, 2023; Volume 51,Issue 4
A
Amilon, Carl
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
Amory, John K.
- You have accessRelevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone DispositionAbdul Basit, John K. Amory, Vijaya Saradhi Mettu, Cindy Yanfei Li, Scott Heyward, Parth B. Jariwala, Matthew R. Redinbo and Bhagwat PrasadDrug Metabolism and Disposition April 2023, 51 (4) 427-435; DOI: https://doi.org/10.1124/dmd.122.000975
Andersson, Linda C.
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Antonsson, Thomas
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
B
Basit, Abdul
- You have accessRelevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone DispositionAbdul Basit, John K. Amory, Vijaya Saradhi Mettu, Cindy Yanfei Li, Scott Heyward, Parth B. Jariwala, Matthew R. Redinbo and Bhagwat PrasadDrug Metabolism and Disposition April 2023, 51 (4) 427-435; DOI: https://doi.org/10.1124/dmd.122.000975
Bhattacharya, Chandrali
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Bragg, Ryan A.
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Bumpus, Namandjé N.
- Open AccessBiotransformation of Efavirenz and Proteomic Analysis of Cytochrome P450s and UDP-Glucuronosyltransferases in Mouse, Macaque, and Human Brain-Derived In Vitro SystemsAbigail M. Wheeler, Benjamin C. Orsburn and Namandjé N. BumpusDrug Metabolism and Disposition April 2023, 51 (4) 521-531; DOI: https://doi.org/10.1124/dmd.122.001195
C
Chang, Qi
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
Cho, Sungjoon
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
D
Dean, Brian
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
De Cock, Pieter
- You have accessPredictive Performance of Physiologically Based Pharmacokinetic Modelling of Beta-Lactam Antibiotic Concentrations in Adipose, Bone, and Muscle TissuesPieter-Jan De Sutter, Pieter De Cock, Trevor N Johnson, Helen Musther, Elke Gasthuys and An VermeulenDrug Metabolism and Disposition April 2023, 51 (4) 499-508; DOI: https://doi.org/10.1124/dmd.122.001129
de Ligt, Rianne A.F.
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
De Sutter, Pieter-Jan
- You have accessPredictive Performance of Physiologically Based Pharmacokinetic Modelling of Beta-Lactam Antibiotic Concentrations in Adipose, Bone, and Muscle TissuesPieter-Jan De Sutter, Pieter De Cock, Trevor N Johnson, Helen Musther, Elke Gasthuys and An VermeulenDrug Metabolism and Disposition April 2023, 51 (4) 499-508; DOI: https://doi.org/10.1124/dmd.122.001129
Ding, Xiao
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
Dou, Yaojie
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
E
Ekdahl, Anja
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
G
Garkaviy, Pavlo
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Gasthuys, Elke
- You have accessPredictive Performance of Physiologically Based Pharmacokinetic Modelling of Beta-Lactam Antibiotic Concentrations in Adipose, Bone, and Muscle TissuesPieter-Jan De Sutter, Pieter De Cock, Trevor N Johnson, Helen Musther, Elke Gasthuys and An VermeulenDrug Metabolism and Disposition April 2023, 51 (4) 499-508; DOI: https://doi.org/10.1124/dmd.122.001129
Gopaul, V. Sashi
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
Gränfors, Malin
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
H
Heijer, Maria
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Heyward, Scott
- You have accessRelevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone DispositionAbdul Basit, John K. Amory, Vijaya Saradhi Mettu, Cindy Yanfei Li, Scott Heyward, Parth B. Jariwala, Matthew R. Redinbo and Bhagwat PrasadDrug Metabolism and Disposition April 2023, 51 (4) 427-435; DOI: https://doi.org/10.1124/dmd.122.000975
Higuchi, Yuichiro
- You have accessThe Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized LiversShotaro Uehara, Yuichiro Higuchi, Nao Yoneda, Hiroaki Kato, Hiroshi Yamazaki and Hiroshi SuemizuDrug Metabolism and Disposition April 2023, 51 (4) 480-491; DOI: https://doi.org/10.1124/dmd.122.001102
Hsu, Jerry Y.
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
I
Inghardt, Tord
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
Isin, Emre M.
- Open AccessUnusual Biotransformation Reactions of Drugs and Drug CandidatesEmre M. IsinDrug Metabolism and Disposition April 2023, 51 (4) 413-426; DOI: https://doi.org/10.1124/dmd.121.000744
J
Jariwala, Parth B.
- You have accessRelevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone DispositionAbdul Basit, John K. Amory, Vijaya Saradhi Mettu, Cindy Yanfei Li, Scott Heyward, Parth B. Jariwala, Matthew R. Redinbo and Bhagwat PrasadDrug Metabolism and Disposition April 2023, 51 (4) 427-435; DOI: https://doi.org/10.1124/dmd.122.000975
Johnson, Trevor N
- You have accessPredictive Performance of Physiologically Based Pharmacokinetic Modelling of Beta-Lactam Antibiotic Concentrations in Adipose, Bone, and Muscle TissuesPieter-Jan De Sutter, Pieter De Cock, Trevor N Johnson, Helen Musther, Elke Gasthuys and An VermeulenDrug Metabolism and Disposition April 2023, 51 (4) 499-508; DOI: https://doi.org/10.1124/dmd.122.001129
Jurva, Ulrik
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
K
Kato, Hiroaki
- You have accessThe Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized LiversShotaro Uehara, Yuichiro Higuchi, Nao Yoneda, Hiroaki Kato, Hiroshi Yamazaki and Hiroshi SuemizuDrug Metabolism and Disposition April 2023, 51 (4) 480-491; DOI: https://doi.org/10.1124/dmd.122.001102
Korzekwa, Ken
- You have accessProcess and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are CorrectKen Korzekwa and Swati NagarDrug Metabolism and Disposition April 2023, 51 (4) 532-542; DOI: https://doi.org/10.1124/dmd.122.001060
L
Leandersson, Carina
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
Li, Cindy Yanfei
- You have accessRelevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone DispositionAbdul Basit, John K. Amory, Vijaya Saradhi Mettu, Cindy Yanfei Li, Scott Heyward, Parth B. Jariwala, Matthew R. Redinbo and Bhagwat PrasadDrug Metabolism and Disposition April 2023, 51 (4) 427-435; DOI: https://doi.org/10.1124/dmd.122.000975
Li, Qing
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Li, Xiong
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Li, Xue-Qing
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
Lindstedt, Eva-Lotte
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Liu, Yujie
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
M
Ma, Shuguang
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
Menakuru, Somasekhara R.
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Mettu, Vijaya Saradhi
- You have accessRelevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone DispositionAbdul Basit, John K. Amory, Vijaya Saradhi Mettu, Cindy Yanfei Li, Scott Heyward, Parth B. Jariwala, Matthew R. Redinbo and Bhagwat PrasadDrug Metabolism and Disposition April 2023, 51 (4) 427-435; DOI: https://doi.org/10.1124/dmd.122.000975
Musther, Helen
- You have accessPredictive Performance of Physiologically Based Pharmacokinetic Modelling of Beta-Lactam Antibiotic Concentrations in Adipose, Bone, and Muscle TissuesPieter-Jan De Sutter, Pieter De Cock, Trevor N Johnson, Helen Musther, Elke Gasthuys and An VermeulenDrug Metabolism and Disposition April 2023, 51 (4) 499-508; DOI: https://doi.org/10.1124/dmd.122.001129
N
Nagar, Swati
- You have accessProcess and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are CorrectKen Korzekwa and Swati NagarDrug Metabolism and Disposition April 2023, 51 (4) 532-542; DOI: https://doi.org/10.1124/dmd.122.001060
O
Orsburn, Benjamin C.
- Open AccessBiotransformation of Efavirenz and Proteomic Analysis of Cytochrome P450s and UDP-Glucuronosyltransferases in Mouse, Macaque, and Human Brain-Derived In Vitro SystemsAbigail M. Wheeler, Benjamin C. Orsburn and Namandjé N. BumpusDrug Metabolism and Disposition April 2023, 51 (4) 521-531; DOI: https://doi.org/10.1124/dmd.122.001195
P
Pang, Jodie
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
Pelay-Gimeno, Marta
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Prasad, Bhagwat
- You have accessRelevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone DispositionAbdul Basit, John K. Amory, Vijaya Saradhi Mettu, Cindy Yanfei Li, Scott Heyward, Parth B. Jariwala, Matthew R. Redinbo and Bhagwat PrasadDrug Metabolism and Disposition April 2023, 51 (4) 427-435; DOI: https://doi.org/10.1124/dmd.122.000975
Q
Qiao, Xiaomeng
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
R
Redinbo, Matthew R.
- You have accessRelevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone DispositionAbdul Basit, John K. Amory, Vijaya Saradhi Mettu, Cindy Yanfei Li, Scott Heyward, Parth B. Jariwala, Matthew R. Redinbo and Bhagwat PrasadDrug Metabolism and Disposition April 2023, 51 (4) 427-435; DOI: https://doi.org/10.1124/dmd.122.000975
S
Sahasranaman, Srikumar
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
Salphati, Laurent
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
Sandinge, Ann-Sofie
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
Shu, Yan
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Suemizu, Hiroshi
- You have accessThe Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized LiversShotaro Uehara, Yuichiro Higuchi, Nao Yoneda, Hiroaki Kato, Hiroshi Yamazaki and Hiroshi SuemizuDrug Metabolism and Disposition April 2023, 51 (4) 480-491; DOI: https://doi.org/10.1124/dmd.122.001102
Sundell, Johan
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
U
Uehara, Shotaro
- You have accessThe Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized LiversShotaro Uehara, Yuichiro Higuchi, Nao Yoneda, Hiroaki Kato, Hiroshi Yamazaki and Hiroshi SuemizuDrug Metabolism and Disposition April 2023, 51 (4) 480-491; DOI: https://doi.org/10.1124/dmd.122.001102
V
Vaes, Wouter H.J.
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Vermeulen, An
- You have accessPredictive Performance of Physiologically Based Pharmacokinetic Modelling of Beta-Lactam Antibiotic Concentrations in Adipose, Bone, and Muscle TissuesPieter-Jan De Sutter, Pieter De Cock, Trevor N Johnson, Helen Musther, Elke Gasthuys and An VermeulenDrug Metabolism and Disposition April 2023, 51 (4) 499-508; DOI: https://doi.org/10.1124/dmd.122.001129
W
Wang, Bin
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
Wang, Pei
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
Wang, Xiaofei
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
Ware, Joseph
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
Weidolf, Lars
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
Westerlund, Kristina
- Open AccessBiotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, Carina Leandersson, Anja Ekdahl, Xue-Qing Li, Thomas Antonsson, Johan Sundell, Kristina Westerlund, Carl Amilon, Tord Inghardt and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 464-479; DOI: https://doi.org/10.1124/dmd.122.001099
Wheeler, Abigail M.
- Open AccessBiotransformation of Efavirenz and Proteomic Analysis of Cytochrome P450s and UDP-Glucuronosyltransferases in Mouse, Macaque, and Human Brain-Derived In Vitro SystemsAbigail M. Wheeler, Benjamin C. Orsburn and Namandjé N. BumpusDrug Metabolism and Disposition April 2023, 51 (4) 521-531; DOI: https://doi.org/10.1124/dmd.122.001195
Wu, Tianyuan
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
X
Xiong, Yalan
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Xiong, Yanling
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Xu, Chen
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
Y
Yamazaki, Hiroshi
- You have accessThe Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized LiversShotaro Uehara, Yuichiro Higuchi, Nao Yoneda, Hiroaki Kato, Hiroshi Yamazaki and Hiroshi SuemizuDrug Metabolism and Disposition April 2023, 51 (4) 480-491; DOI: https://doi.org/10.1124/dmd.122.001102
Yan, Jingjing
- Open AccessApplication of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf and V. Sashi GopaulDrug Metabolism and Disposition April 2023, 51 (4) 451-463; DOI: https://doi.org/10.1124/dmd.122.001100
Yang, Haijun
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Yang, Weihong
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
Yoneda, Nao
- You have accessThe Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized LiversShotaro Uehara, Yuichiro Higuchi, Nao Yoneda, Hiroaki Kato, Hiroshi Yamazaki and Hiroshi SuemizuDrug Metabolism and Disposition April 2023, 51 (4) 480-491; DOI: https://doi.org/10.1124/dmd.122.001102
Z
Zhang, Lirong
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
Zhang, Wei
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Zhang, Yanjuan
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Zhang, Zhe
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
Zhao, Huan
- You have accessCYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 CellsWeihong Yang, Huan Zhao, Yaojie Dou, Pei Wang, Qi Chang, Xiaomeng Qiao, Xiaofei Wang, Chen Xu, Zhe Zhang and Lirong ZhangDrug Metabolism and Disposition April 2023, 51 (4) 492-498; DOI: https://doi.org/10.1124/dmd.122.001111
Zhao, Weiping
- You have accessAbsorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and HumansShuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware and Laurent SalphatiDrug Metabolism and Disposition April 2023, 51 (4) 436-450; DOI: https://doi.org/10.1124/dmd.122.001096
Zhou, Honghao
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Zhou, Jian
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Zhou, Rong
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
Zhu, Peng
- You have accessAntibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsHaijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li and Qing LiDrug Metabolism and Disposition April 2023, 51 (4) 509-520; DOI: https://doi.org/10.1124/dmd.122.001173
In this issue

Advertisement